生物活性 | |||
---|---|---|---|
靶点 |
|
||
描述 | Pancuronium Dibromide is a competitive AChR antagonist.Pancuronium (10 mg/kg ) reduced ACh-induced bronchoconstriction. At doses which produce 100% neuromuscular blockade, both pancuronium (0.04 mg/kg) and gallamine (4 mg/kg) potentiated vagally-induced bronchoconstriction[3].Competitive block of embryonic-type nicotinic acetylcholine receptor channels by pancuronium or atracurium after preincubation of outside-out patches with the respective blocker[4]. Moreover, Pancuronium may reduce the sodium current by interacting with the sodium channels in both the resting and open states[5]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.36mL 0.27mL 0.14mL |
6.82mL 1.36mL 0.68mL |
13.65mL 2.73mL 1.36mL |
参考文献 |
---|